2024年8月 英文論文
NHO所属の著者を含む英文論文が177報出版されました。
内訳:北海道がんセンター(3)、北海道医療センター(2)、函館病院(1)、旭川医療センター(3)、岩手病院(1)、仙台医療センター(4)、水戸医療センター(4)、栃木医療センター(2)、高崎総合医療センター(3)、渋川医療センター(2)、埼玉病院(3)、下志津病院(1)、東京医療センター(5)、災害医療センター(2)、東京病院(6)、横浜医療センター(3)、久里浜医療センター(1)、相模原病院(3)、西新潟中央病院(1)、新潟病院(1)、甲府病院(1)、信州上田医療センター(1)、金沢医療センター(1)、医王病院(1)、静岡医療センター(1)、名古屋医療センター(13)、豊橋医療センター(1)、三重病院(2)、鈴鹿病院(1)、あわら病院(1)、京都医療センター(13)、宇多野病院(2)、舞鶴医療センター(1)、大阪医療センター(14)、近畿中央呼吸器センター(4)、大阪刀根山医療センター(3)、大阪南医療センター(1)、姫路医療センター(4)、兵庫中央病院(1)、和歌山病院(1)、米子医療センター(2)、岡山医療センター(3)、呉医療センター(5)、福山医療センター(1)、山口宇部医療センター(1)、岩国医療センター(1)、四国がんセンター(12)、高知病院(2)、九州がんセンター(9)、九州医療センター(5)、大牟田病院(2)、肥前精神医療センター(1)、嬉野医療センター(3)、長崎医療センター(2)、熊本医療センター(1)、別府医療センター(1)、都城医療センター(2)、宮崎病院(3)、鹿児島医療センター(3)
北海道がんセンター
#腫瘍学
Noguchi E, Yamanaka T, Mukai H, Yamamoto N, Chung CF, Lu YS, Chang DY,
Sohn J, Kim GM, Lee KH, Lee SC, Iwasa T, Iwata H, Watanabe K,
Jung KH, Tanabe Y, Kang SY, Yasojima H, Aogi K,
Tokunaga E, Sim SH, Yap YS, Matsumoto K, Tseng LM, Umeyama Y,
Sudo K, Kojima Y, Hata T, Kuchiba A, Shibata T, Nakamura K, Fujiwara
Y, Tamura K, Yonemori K
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients
with HR-positive/HER2-negative advanced breast cancer
npj Breast Cancer. 2024 AUG 22;10(1)
Journal Impact Factor 2021: 7.519
#腫瘍学
Nakatsumi H, Komatsu Y, Harada K, Kawamoto Y, Yuki S, Sawada K,
Ishiguro A, Sogabe S, Ando T, Sasaki Y, Yoshikawa A, Nakamura M, Dazai
M, Tateyama M, Muto O, Kotaka M, Sagawa T, Muranaka T, Hatanaka
K, Takagi R, Sakata Y
A multicenter, prospective, phase II trial of second-line
aflibercept plus FOLFIRI in patients with metastatic colorectal
cancer refractory to an anti-EGFR antibody: HGCSG1801
Int J Cancer. 2024 DEC 15;155(12):2223-2231.
Journal Impact Factor 2021: 7.316
#腫瘍学
Nakayama T, Niikura N, Yamanaka T, Yamamoto M, Matsuura K,
Inoue K, Takahara S, Nomura H, Kita S, Yamaguchi M, Aruga T, Shibata
N, Shimomura A, Ozaki Y, Sakai S, Takiguchi D, Takata T, Bastanfard A,
Shiosakai K, Tsurutani J
Trastuzumab deruxtecan for the treatment of patients with
HER2-positive breast cancer with brain and/or leptomeningeal
metastases: an updated overall survival analysis using data from a
multicenter retrospective study (ROSET-BM)
Breast Cancer. 2024 NOV;31(6):1167-1175.
Journal Impact Factor 2021: 3.307
北海道医療センター
#臨床神経学 #レビュー論文
Niino M, Isobe N, Araki M, Ohashi T, Okamoto T, Ogino M, Okuno
T, Ochi H, Kawachi I, Shimizu Y, Takahashi K, Takeuchi H,
Tahara M, Chihara N, Nakashima I, Fukaura H, Misu T,
Miyazaki Y, Miyamoto K, Mori M, Kinoshita M, Takai Y, Fujii C,
Watanabe M, Fujihara K
Clinical practice guidelines for multiple sclerosis, neuromyelitis
optica spectrum disorder, and myelin oligodendrocyte glycoprotein
antibody-associated disease 2023 in Japan
Mult Scler Relat Disord. 2024 OCT;90
Journal Impact Factor 2021: 4.808
#腫瘍学
Nakatsumi H, Komatsu Y, Harada K, Kawamoto Y, Yuki S, Sawada K,
Ishiguro A, Sogabe S, Ando T, Sasaki Y, Yoshikawa A, Nakamura M, Dazai
M, Tateyama M, Muto O, Kotaka M, Sagawa T, Muranaka T, Hatanaka
K, Takagi R, Sakata Y
A multicenter, prospective, phase II trial of second-line
aflibercept plus FOLFIRI in patients with metastatic colorectal
cancer refractory to an anti-EGFR antibody: HGCSG1801
Int J Cancer. 2024 DEC 15;155(12):2223-2231.
Journal Impact Factor 2021: 7.316
函館病院
#心臓 #循環器系 #多施設共同研究
Koya T, Nagai T, Tada A, Nakao M, Ishizaka S, Mizuguchi Y, Aoyagi H,
George F, Imagawa S, Tokuda Y, Kato Y, Takahashi M, Sakai H,
Machida M, Matsutani K, Saito T, Okamoto H, Anzai T, ELMSTAT-HF
Investigators
Differential impacts of self-care behavior on clinical outcomes in
patients with and without recent heart failure hospitalization
Int J Cardiol. 2024 NOV 15;415
Journal Impact Factor 2021: 4.039
旭川医療センター
#臨床神経学
Aizawa H, Nagumo S, Hideyama T, Kato H, Kwak S, Terashi H,
Suzuki Y, Kimura T
Morphometric analysis of spinal motor neuron degeneration in
sporadic amyotrophic lateral sclerosis
J Neurol Sci. 2024 SEP 15;464
Journal Impact Factor 2021: 4.553
#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D,
Isa SI, Nakamura K, Mizumori Y,
Shinohara T, Yanai H, Nakatomi K, Oki M,
Mori M, Kuwako T, Yamazaki K, Tamura A,
Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib
treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC
based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32
#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y,
Nakamura K, Mizumori Y, Shinohara T,
Yanai H, Nakatomi K, Oki M, Mori M,
Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment
co-alterations and p-prognosis to osimertinib in chemo-naïve
advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081
岩手病院
#複合科学
Suzuki N, Kanzaki M, Koide M, Izumi R, Fujita R, Takahashi T, Ogawa K,
Yabe Y, Tsuchiya M, Suzuki M, Harada R, Ohno A, Ono H, Nakamura
N, Ikeda K, Warita H, Osana S, Oikawa Y, Toyohara T, Abe T, Rui ML,
Ebihara S, Nagatomi R, Hagiwara Y, Aoki M
Sporadic inclusion body myositis-derived myotube culture revealed
muscle cell-autonomous expression profiles
PLoS One. 2024 AUG 1;19(8)
Journal Impact Factor 2021: 3.752
仙台医療センター
#臨床神経学
Ohata K, Arai H, Ezura M, Iihara K, Kinouchi H, Kobayashi S,
Tominaga T, Minematsu K, Murayama Y, Nakayama N, Sakai N,
Yasaka M, Yoshimoto Y, Kobayashi S
Nationwide All-case Survey on the Efficacy and Safety of Flow
Diverter: Multicenter Study Conducted by the Japan Neurosurgical
Society
Neurol Med-Chir. 2024 AUG;64:1-106.
Journal Impact Factor 2021: 2.036
#複合科学
Fan YX, Nishimura H, Sakata S, Okada Y, Ebihara S, Tang
JW, Kohzuki M
Minimal influenza virus transmission from touching contaminated
face masks: a laboratory study
Sci Rep. 2024 AUG 30;14(1)
Journal Impact Factor 2021: 4.997
#放射線学 #核医学 #医用画像
Okuno T, Watanabe T, Yamaguchi T, Konno S, Takaki R, Watanabe
R, Ban KAK, Hirokaga K, Tsuruoka M, Morita T
Usefulness of color Doppler and strain elastography adjunctive to
B-mode ultrasonography in the diagnosis of non-mass abnormalities of
the breast: results of the BC-07 multicenter study of 385 cases
J Med Ultrason. 2024 AUG 13;
Journal Impact Factor 2021: 1.878
#公衆衛生学 #環境衛生学 #労働衛生学
Koga M, Fukuda A, Nojima M, Ishizaka A, Itoh T, Eguchi S, Endo
T, Kakinuma A, Kinai E, Goto T, Takahashi S, Takeda H, Tanaka T,
Teruya K, Hanai J, Fujii T, Fujitani J, Hosaka T, Mita E,
Minami R, Moro H, Yokomaku Y, Watanabe D,
Watanabe T, Yotsuyanagi H
Non-acquired immunodeficiency syndrome defining malignancies in
people living with haemophilia and human immunodeficiency virus
after direct-acting antiviral era
Glob Health Medicine. 2024;6(5):316-323.
水戸医療センター
#免疫学 #観察研究 #多施設共同研究
Unagami K, Yoshikawa M, Egawa H, Ohfuji S, Natori Y, Oki R, Mori T,
Hattori H, Ishiwatari A, Kanzawa T, Shimizu T, Omoto K, Inui M, Masano
Y, Ito T, Nakajima D, Babazono T, Takagi T, Nunoda S, Tomimaru Y,
Imamura R, Miyagawa S, Toda K, Hatano E, Date H, Kyakuno M, Takahara
S, Yuzawa K, Tanimine N, Ohdan H, Ishida H, Hirota Y, Japan
Solid Organ Transplantation COVID 19 Countermeasure Grp
Delayed peak antibody titers after the second dose of SARS-CoV-2
vaccine in solid organ transplant recipients: Prospective cohort
study
Vaccine. 2024 OCT 3;42(23)
Journal Impact Factor 2021: 4.169
#神経科学
Aoki J, Suzuki K, Sakamoto Y, Matsumaru Y, Takeuchi M, Morimoto M,
Kanazawa R, Takayama Y, Kamiya Y, Shigeta K, Okubo S, Hayakawa
M, Ishii N, Koguchi Y, Takigawa T, Inoue M, Naito H, Ota T,
Hirano T, Kato N, Ueda T, Iguchi Y, Akaji K, Tsuruta W, Miki K,
Fujimoto S, Higashida T, Iwasaki M, Kanamaru T, Saito T, Katano T,
Kutsuna A, Nishiyama Y, Otsuka T, Kimura K, SKIP study Investigators
High plasma BNP concentration associates with clinical outcome
after mechanical thrombectomy: Post hoc analysis of SKIP
J Stroke Cerebrovasc Dis. 2024 NOV;33(11)
Journal Impact Factor 2021: 2.677
#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D,
Isa SI, Nakamura K, Mizumori Y,
Shinohara T, Yanai H, Nakatomi K, Oki M,
Mori M, Kuwako T, Yamazaki K, Tamura A,
Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib
treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC
based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32
#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y,
Nakamura K, Mizumori Y, Shinohara T,
Yanai H, Nakatomi K, Oki M, Mori M,
Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment
co-alterations and p-prognosis to osimertinib in chemo-naïve
advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081
栃木医療センター
#免疫学
Shinjoh M, Yaginuma M, Yamaguchi Y, Tamura K, Furuichi M,
Tsumura Y, Itaki R, Iqbal A, Maeda N, Narabayashi A,
Kamei A, Shibata A, Yamada G, Nishida M, Kenichiro T, Chiga M,
Shimoyamada M, Yoshida M, Fukushima N, Nakata Y, Fukushima H, Kawakami
C, Narumi S, Sugaya N, Keio Pediatric Influenza Res Grp
Effectiveness of inactivated influenza vaccine in children during
the 2023/ 24 season: The first season after relaxation of intensive
COVID-19 measures
Vaccine. 2024 OCT 3;42(23)
Journal Impact Factor 2021: 4.169
#外科学 #症例報告
Yabusaki R, Arai A, Odagaki Y, Nakashima J, Nakamura K,
Ishikawa H, Okonogi N, Aoki S, Tsuji H, Ozu C
Salvage robotic-assisted radical prostatectomy in a patient with
recurrence after two sessions of heavy ion radiotherapy
J Surg Case Rep. 2024 AUG 19;2024(8)
Journal Impact Factor 2021: N/A
高崎総合医療センター
#心臓 #循環器系
Hatori K, Mohara J, Shibata S, Murata M,
Fukuda N, Hiroi S, Koyano T
Cardiac calcified amorphous tumor in a patient with lung cancer
Gen Thorac Cardiovasc Surg Cases. 2024 AUG 13;3(1)
#腫瘍学
Hatanaka T, Saito N,
Kakizaki S, Hiraoka A, Tada T, Kariyama K, Tani J, Takaguchi K, Itobayashi E,
Ishikawa T, Toyoda H, Kawata K, Naganuma A, Yata Y, Ohama H,
Matono T, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Nakamura
S, Kumada T, Real Life Practice Experts HCC RELPEC Study Grp
Factors Affecting an Increase in Spleen Volume and Association of
Spleen Volume Variation with the Clinical Outcomes of Atezolizumab
and Bevacizumab Treatment for Hepatocellular Carcinoma: A
Retrospective Analysis
Oncology. 2024 AUG 20;
Journal Impact Factor 2021: 3.734
#医学 #一般医療 #内科学 #症例報告
Tomaru N, Nakamura H, Makiguchi T, Yamada Y,
Yokoo S
Necrotizing Fasciitis of the Lower Extremity Treated With
Continuous Local Antibiotic Perfusion
Cureus J Med Sci. 2024 AUG 14;16(8)
Journal Impact Factor 2021: N/A
渋川医療センター
#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D,
Isa SI, Nakamura K, Mizumori Y,
Shinohara T, Yanai H, Nakatomi K, Oki M,
Mori M, Kuwako T, Yamazaki K, Tamura A,
Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib
treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC
based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32
#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y,
Nakamura K, Mizumori Y, Shinohara T,
Yanai H, Nakatomi K, Oki M, Mori M,
Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment
co-alterations and p-prognosis to osimertinib in chemo-naïve
advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081
埼玉病院
#免疫学
Shinjoh M, Yaginuma M, Yamaguchi Y, Tamura K, Furuichi M,
Tsumura Y, Itaki R, Iqbal A, Maeda N, Narabayashi A,
Kamei A, Shibata A, Yamada G, Nishida M, Kenichiro T, Chiga M,
Shimoyamada M, Yoshida M, Fukushima N, Nakata Y, Fukushima H, Kawakami
C, Narumi S, Sugaya N, Keio Pediatric Influenza Res Grp
Effectiveness of inactivated influenza vaccine in children during
the 2023/ 24 season: The first season after relaxation of intensive
COVID-19 measures
Vaccine. 2024 OCT 3;42(23)
Journal Impact Factor 2021: 4.169
#薬理学 #薬学
Ishimura A, Ogawa C, Yatabe M, Tani K, Inoue M
Differences in fluidity and viscosity of brand-name and generic
injectable ointment
Drug Discov Ther. 2024 AUG;18(4):265-268.
Journal Impact Factor 2021: N/A
#外科学
Ichikawa K, Tomita A, Suzuki Y, Hosoda S, Koto T, Inoue M
Isolated posterior capsule rupture secondary to blunt ocular
trauma: Case presentation and literature review
Int J Surg Case Rep. 2024 SEP;122
Journal Impact Factor 2021: N/A
下志津病院
#整形外科学
Suzuki N, Eguchi Y, Hirai T, Takahashi T, Takahashi Y,
Watanabe K, Banno T, Sakaki K, Maki S, Takano Y, Taniguchi Y, Aoki Y,
Konishi T, Hiraizumi Y, Yamagata M, Hirakawa A, Ohtori S
Outcome of intradiscal condoliase injection therapy for patients
with recurrent lumbar disc herniation
Asian Spine J. 2024 AUG;18(4):550-559.
Journal Impact Factor 2021: N/A
東京医療センター
#免疫学
Shinjoh M, Yaginuma M, Yamaguchi Y, Tamura K, Furuichi M,
Tsumura Y, Itaki R, Iqbal A, Maeda N, Narabayashi A,
Kamei A, Shibata A, Yamada G, Nishida M, Kenichiro T, Chiga M,
Shimoyamada M, Yoshida M, Fukushima N, Nakata Y, Fukushima H, Kawakami
C, Narumi S, Sugaya N, Keio Pediatric Influenza Res Grp
Effectiveness of inactivated influenza vaccine in children during
the 2023/ 24 season: The first season after relaxation of intensive
COVID-19 measures
Vaccine. 2024 OCT 3;42(23)
Journal Impact Factor 2021: 4.169
#薬理学 #薬学
Ishimura A, Ogawa C, Yatabe M, Tani K, Inoue M
Differences in fluidity and viscosity of brand-name and generic
injectable ointment
Drug Discov Ther. 2024 AUG;18(4):265-268.
Journal Impact Factor 2021: N/A
#腫瘍学 #多施設共同研究
Shimizu H, Kodaira T, Kiyota N, Hayashi R, Nishino H, Asada Y, Mitani
H, Hirayama Y, Onozawa Y, Nishio N, Hanai N, Ohkoshi A, Hara H,
Monden N, Nagaoka M, Minami S, Fujii T, Tanaka K, Homma
A, Yoshimoto S, Oridate N, Omori K, Ueda T, Okami K, Uemura H, Shiga
K, Nakahira M, Asakage T, Saito Y, Sasaki K, Kitabayashi R, Ishikura
S, Nishimura Y, Tahara M
Incidence and risk factors associated with the development of
hypothyroidism after postoperative chemoradiotherapy for head and
neck cancer patients with high-risk features: Supplementary analysis
of JCOG1008
Oral Oncol. 2024 OCT;157
Journal Impact Factor 2021: 5.972
#医学 #研究 #実験
Wasano K, Nakagawa T, Kaga K, Ogawa K
The effect of aging and asymmetrical hearing on speech
discrimination
Communications Med. 2024 AUG 21;4(1)
#外科学
Mizuno S, Shigeta K, Kato Y, Okui J, Morita S, Sonal S, Goldstone R,
Berger D, Al-Masri R, Al-Masri M, Tajima Y, Kikuchi H, Hirata A,
Nakadai J, Baba H, Sugiura K, Hoshino G, Seo Y, Makino A, Suzumura H,
Suzuki Y, Adachi Y, Shimada T, Kondo T, Matsui S,
Seishima R, Okabayashi K, Kitagawa Y, Kunitake H
Stratification of Stage II Colon Cancer Using Recurrence Prediction
Value
Ann Surg. 2024 AUG;280(2):274-282.
Journal Impact Factor 2021: 13.787
災害医療センター
#神経科学
Aoki J, Suzuki K, Sakamoto Y, Matsumaru Y, Takeuchi M, Morimoto M,
Kanazawa R, Takayama Y, Kamiya Y, Shigeta K, Okubo S, Hayakawa
M, Ishii N, Koguchi Y, Takigawa T, Inoue M, Naito H, Ota T,
Hirano T, Kato N, Ueda T, Iguchi Y, Akaji K, Tsuruta W, Miki K,
Fujimoto S, Higashida T, Iwasaki M, Kanamaru T, Saito T, Katano T,
Kutsuna A, Nishiyama Y, Otsuka T, Kimura K, SKIP study Investigators
High plasma BNP concentration associates with clinical outcome
after mechanical thrombectomy: Post hoc analysis of SKIP
J Stroke Cerebrovasc Dis. 2024 NOV;33(11)
Journal Impact Factor 2021: 2.677
#神経科学
Ishikawa M, Takahashi S, Hirai S, Sato Y, Shigeta K, Yoshimura
M, Yamamura T, Taira N, Ishiwada T, Karakama J, Sawada K, Obata Y,
Yamada K, Yoshino Y, Ishii Y, Wakabayashi H, Fujita K, Fujii S, Sagawa
H, Nemoto S, Maehara T, Sumita K
Efficacy of endovascular treatment for distal anterior cerebral
artery aneurysms: A multicenter observational study
J Stroke Cerebrovasc Dis. 2024 NOV;33(11)
Journal Impact Factor 2021: 2.677
東京病院
#呼吸器系
Iida T, Sato M, Fukami T
Clinical analysis of progressive destroyed lung after lung cancer
surgery
J Thorac Dis. 2024 AUG;16(8):5097-5109.
Journal Impact Factor 2021: 3.005
#呼吸器系 #レビュー論文
Kimura Y, Jo T, Matsui H, Yasunaga H
Clinical research using real-world data: A narrative review
Respir Investig. 2024 NOV;62(6):929-934.
Journal Impact Factor 2021: N/A
#神経科学
Aoki J, Suzuki K, Sakamoto Y, Matsumaru Y, Takeuchi M, Morimoto M,
Kanazawa R, Takayama Y, Kamiya Y, Shigeta K, Okubo S, Hayakawa
M, Ishii N, Koguchi Y, Takigawa T, Inoue M, Naito H, Ota T,
Hirano T, Kato N, Ueda T, Iguchi Y, Akaji K, Tsuruta W, Miki K,
Fujimoto S, Higashida T, Iwasaki M, Kanamaru T, Saito T, Katano T,
Kutsuna A, Nishiyama Y, Otsuka T, Kimura K, SKIP study Investigators
High plasma BNP concentration associates with clinical outcome
after mechanical thrombectomy: Post hoc analysis of SKIP
J Stroke Cerebrovasc Dis. 2024 NOV;33(11)
Journal Impact Factor 2021: 2.677
#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D,
Isa SI, Nakamura K, Mizumori Y,
Shinohara T, Yanai H, Nakatomi K, Oki M,
Mori M, Kuwako T, Yamazaki K, Tamura A,
Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib
treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC
based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32
#リウマチ学
Higuchi T, Oka S, Shimada K, Tsunoda S, Ito S,
Okamoto A, Fujimori M, Nakamura T, Katayama M,
Suzuki M, Saisho K, Shinohara S, Matsui T,
Migita K, Nagaoka S, Tohma S, Furukawa H
Association of rare single-nucleotide variant MUC5B rs35705950 with
interstitial lung disease in Japanese rheumatoid arthritis
RHEUMATOLOGY. 2024 AUG 19;
Journal Impact Factor 2021: 7.046
#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y,
Nakamura K, Mizumori Y, Shinohara T,
Yanai H, Nakatomi K, Oki M, Mori M,
Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment
co-alterations and p-prognosis to osimertinib in chemo-naïve
advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081
横浜医療センター
#心臓 #循環器系
Matsui Y, Higuchi S, Mori F, Takehisa K,
Kikuchi K, Kikuchi H, Hirobe K, Maeda R,
Tsukamoto K, Saito T, Shoda M, Yamaguchi J
Microporous polysaccharide hemospheres for reducing pocket
hematomas after cardiac device implantation in patients on
antithrombotic therapy
J Arrythm. 2024 OCT;40(5):1150-1157.
Journal Impact Factor 2021: N/A
#泌尿器学 #腎臓学 #症例報告
Takanashi M, Asaoka M, Imano M, Fujioka A,
Oishi Y, Matsuda G, Chiba S, Hirai K
Primary squamous cell carcinoma of the kidney with hepatic
invasion
IJU Case Rep. 2024 SEP;7(5):408-413.
#臨床神経学
Kamogawa M, Tanino S, Miyahara K, Shuto T,
Matsunaga S, Okada T, Noda N, Sekiguchi N,
Suzuki K, Tanaka Y, Uriu Y
Surgical and radiosurgical outcomes for Koos grade 3 vestibular
schwannomas
Neurosurg Rev. 2024 AUG 3;47(1)
Journal Impact Factor 2021: 2.8
久里浜医療センター
#心理学 #総合
Kawashima D, Kempe T, Koga Y, Kubota S, Tsujimoto T, Urata Y,
Watanabe T, Kondo-Arita M
Development and Initial Validation of the Death Attitudes in
Relationships Scale
Jpn Psychol Res. 2024 AUG 6;
DOI:
10.1111/jpr.12543 WoS:
WOS:001284400500001
相模原病院
#アレルギー #レビュー論文
Tanno LK, Perie A, Bernstein JA, Sublett JL, Davtyan K, Berard F,
Pawankar R, Rostan MV, Chong HRR, Yanez A, Ansontegui IJ,
Ebisawa M, Wong GWK, Morais-Almeida M, Martin B, Briand Y,
Demoly P, Amer Acad Allergy Asthma & Immunology AAAAI, Amer Coll
Allergy Asthma & Immunology ACAAI, Asia Pacific Association
Allergy Asthma & Clinical Immunology APAAACI, French Allergy Soc,
French WHO Collaborating Ctr, WHO Regional Off Europe, Latin Amer Soc
Allergy & Immunology SLAAI, Montpellier WHO Collaborating Ctr
World Allergy Org WAO
Allergic and hypersensitivity condition in the International
Patients' Summary (IPS) standard: The need of updates through the
International Classification of Diseases (ICD)-11
World Allergy Organ J. 2024 AUG;17(8)
Journal Impact Factor 2021: 5.516
#リウマチ学
Higuchi T, Oka S, Shimada K, Tsunoda S, Ito S,
Okamoto A, Fujimori M, Nakamura T, Katayama M,
Suzuki M, Saisho K, Shinohara S, Matsui T,
Migita K, Nagaoka S, Tohma S, Furukawa H
Association of rare single-nucleotide variant MUC5B rs35705950 with
interstitial lung disease in Japanese rheumatoid arthritis
RHEUMATOLOGY. 2024 AUG 19;
Journal Impact Factor 2021: 7.046
#アレルギー #レビュー論文
Leung ASY, Pacharn P, Tangvalelerd S, Sato S, Pitt E, Wong G,
Koplin JJ
Food allergy in a changing dietary landscape: A focus on the Asia
Pacific region
Pediatr Allergy Immunol. 2024 AUG;35(8)
Journal Impact Factor 2021: 5.464
西新潟中央病院
#遺伝学 #遺伝
Tamura T, Yamamoto KS,
Tohyama J, Morioka I, Kanno H, Yamamoto T
Reciprocal chromosome translocation t(3;4)(q27;q31.2) with deletion
of 3q27 and reduced FBXW7 expression in a patient with
developmental delay, hypotonia, and seizures
J Hum Genet. 2024 DEC 1;69(12):639-644.
Journal Impact Factor 2021: 3.767
新潟病院
#臨床神経学
Hirayama T, Morioka H, Sugisawa T, Shibukawa M, Ebina J, Hanashiro S,
Nagasawa J, Yanagihashi M, Okuni I, Nakajima T, Murakami Y,
Yamanaka K, Ebihara S, Kano O
A preliminary study on the effects of long-term robot suit exercise
training on gait function and quality of life in patients with
spinal and bulbar muscular atrophy
J Clin Neurosci. 2024 OCT;128
Journal Impact Factor 2021: 2.116
甲府病院
#整形外科学 #症例報告 #レビュー論文
Kono H, Saito M, Sato N, Ochiai S,
Ichikawa J, Wako M, Haro H, Hagino T
Chronic dislocations of the fourth and fifth carpometacarpal joints
with successful treatment by ligament repair: A case report and
literature review
Joint Dis Relat Surg. 2024;35(3):699-705.
Journal Impact Factor 2021: 1.549
信州上田医療センター
#腫瘍学 #多施設共同研究
Ozawa R, Sonehara K, Hachiya T, Nozawa S, Agatsuma T, Yamamoto
H, Kato A, Matsuo A, Hirabayashi T, Araki T, Komatsu M, Tateishi K,
Hanaoka M
Evaluation of the association between predictive factors and the
development of immune-related adverse events and prognostic factors
for chemoimmunotherapy in patients with non-small cell lung cancer:
A multicenter retrospective study
Cancer Med. 2024 AUG;13(15)
Journal Impact Factor 2021: 4.711
金沢医療センター
#公衆衛生学 #環境衛生学 #労働衛生学
Sakai T, Ueda Y, Yanagisawa H, Arita K, Iwao H, Yamada K, Mizuta S,
Kawabata H, Fukushima T, Tai KTNR, Kishi S, Morinaga K,
Murakami J, Takamatsu H, Terasaki Y, Yoshio N, Kondo Y, Okumura
H, Matano S, Yamaguchi M, Tsutani H, Masaki Y
Prospective therapeutic studies of disseminated extranodal large
B-cell lymphoma including intravascular large B-cell lymphoma
Glob Health Medicine. 2024;6(4):277-281.
医王病院
#臨床神経学 #レビュー論文
Niino M, Isobe N, Araki M, Ohashi T, Okamoto T, Ogino M, Okuno
T, Ochi H, Kawachi I, Shimizu Y, Takahashi K, Takeuchi H,
Tahara M, Chihara N, Nakashima I, Fukaura H, Misu T,
Miyazaki Y, Miyamoto K, Mori M, Kinoshita M, Takai Y, Fujii C,
Watanabe M, Fujihara K
Clinical practice guidelines for multiple sclerosis, neuromyelitis
optica spectrum disorder, and myelin oligodendrocyte glycoprotein
antibody-associated disease 2023 in Japan
Mult Scler Relat Disord. 2024 OCT;90
Journal Impact Factor 2021: 4.808
静岡医療センター
#末梢血管疾患
Naito N, Takagi H
Systematic Review and Meta-Analysis With Reconstructed
Time-To-Event Data of Frozen Elephant Trunk and Conventional Aortic
Repair
Angiology. 2024 AUG 12;
Journal Impact Factor 2021: 3.299
名古屋医療センター
#血液学
Goto H, Kada A, Ogawa C, Nishiuchi R, Yamanaka J, Iguchi A,
Nishi M, Sakaguchi K, Kumamoto T, Mochizuki S, Ueki H, Kosaka Y,
Saito AM, Toyoda H
Treatment of relapsed acute lymphoblastic leukemia in children: an
observational study of the Japan Children's Cancer Group
Int J Hematol. 2024 NOV;120(5):631-638.
Journal Impact Factor 2021: 2.324
#病理学
Toriyama K, Uehara T, Iwakoshi A, Kawashima H, Hosoda W
HNF6 and HNF4α expression in adenocarcinomas of the liver,
pancreaticobiliary tract, and gastrointestinal tract: an
immunohistochemical study of 480 adenocarcinomas of the digestive
system
Pathology. 2024 OCT;56(6):804-813.
Journal Impact Factor 2021: 5.335
#腫瘍学
Yamamoto Y, Yukami H, Yamaguchi T, Ohori H, Nagasu S, Kagawa Y,
Sugimoto N, Sonoda H, Yamazaki K, Takashima A, Okuyama H,
Hasegawa H, Kondo C, Baba E, Matsumoto T, Kawamoto Y,
Kataoka M, Shindo Y, Ishikawa T, Esaki T, Kito Y, Sato
T, Funakoshi T, Yamaguchi T, Shimada Y, Moriwaki T
Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with
metastatic colorectal cancer: the JSCCR-TRIPON study
Int J Clin Oncol. 2024 AUG 28;
Journal Impact Factor 2021: 3.85
#腫瘍学
Akechi T, Furukawa TA, Hashimoto H, Harada Y, Ito Y, Furukawa
Y, Kitano A, Maeda N, Kojima Y, Tada Y, Watanabe A, Kurata A,
Matsubara T, Sakurai N, Uchitomi Y, Okamura M, Fujimori M
Smartphone-based distress screening, information provision, and
psychotherapy for reducing psychological distress among AYA cancer
survivors: protocol for a fully decentralized multicenter randomized
controlled clinical trial
Jpn J Clin Oncol. 2024 AUG 28;54(12):1351-1357.
Journal Impact Factor 2021: 2.925
#血液学
Goto H, Kada A, Ogawa C, Nishiuchi R, Yamanaka J, Iguchi A,
Nishi M, Sakaguchi K, Kumamoto T, Mochizuki S, Ueki H, Kosaka Y,
Saito AM, Toyoda H
Treatment of relapsed acute lymphoblastic leukemia in children: an
observational study of the Japan Children's Cancer Group
Int J Hematol. 2024 AUG 27;
Journal Impact Factor 2021: 2.324
#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D,
Isa SI, Nakamura K, Mizumori Y,
Shinohara T, Yanai H, Nakatomi K, Oki M,
Mori M, Kuwako T, Yamazaki K, Tamura A,
Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib
treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC
based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32
#腫瘍学
Hosoi H, Miyachi M, Teramukai S, Sakabayashi S, Tsuchiya K, Kuwahara
Y, Onodera R, Matsuyama K, Yokota I, Hojo H, Okita H, Hata JI,
Hamasaki M, Tsuneyoshi M, Oda Y, Nakazawa A, Kato M, Takimoto T,
Horibe K, Hara JI, Suita S, Hanada R, Masaki H, Nozaki M, Ikeda
H, Kishimoto S, Kaneko M, Kawai A, Morikawa Y
Results of the JRS-I LRA0401 and LRB0402 Japan Rhabdomyosarcoma
Study Group trials for low-risk embryonal rhabdomyosarcoma
Int J Clin Oncol. 2024 NOV;29(11):1746-1755.
Journal Impact Factor 2021: 3.85
#血液学
Yokota H, Miyao K, Sawa M, Terakura S, Kurahashi S, Ikoma Y,
Imahashi N, Morishita T, Okamoto A, Kajiguchi T, Ono T, Narita
T, Kanemura N, Ozeki K, Kojima Y, Naito K, Uchino K, Tomita A,
Iida H, Imoto N, Kasahara S, Inagaki Y, Nishida T, Murata M,
Nagoya Blood & Marrow Transplantat Grp
Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive
Therapy for Newly Diagnosed Severe Aplastic Anemia
J Hematol. 2024 AUG;13(4):142-149.
Journal Impact Factor 2021: N/A
#リウマチ学
Higuchi T, Oka S, Shimada K, Tsunoda S, Ito S,
Okamoto A, Fujimori M, Nakamura T, Katayama M,
Suzuki M, Saisho K, Shinohara S, Matsui T,
Migita K, Nagaoka S, Tohma S, Furukawa H
Association of rare single-nucleotide variant MUC5B rs35705950 with
interstitial lung disease in Japanese rheumatoid arthritis
RHEUMATOLOGY. 2024 AUG 19;
Journal Impact Factor 2021: 7.046
#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y,
Nakamura K, Mizumori Y, Shinohara T,
Yanai H, Nakatomi K, Oki M, Mori M,
Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment
co-alterations and p-prognosis to osimertinib in chemo-naïve
advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081
#放射線学 #核医学 #医用画像
Okuno T, Watanabe T, Yamaguchi T, Konno S, Takaki R, Watanabe
R, Ban KAK, Hirokaga K, Tsuruoka M, Morita T
Usefulness of color Doppler and strain elastography adjunctive to
B-mode ultrasonography in the diagnosis of non-mass abnormalities of
the breast: results of the BC-07 multicenter study of 385 cases
J Med Ultrason. 2024 AUG 13;
Journal Impact Factor 2021: 1.878
#公衆衛生学 #環境衛生学 #労働衛生学
Koga M, Fukuda A, Nojima M, Ishizaka A, Itoh T, Eguchi S, Endo
T, Kakinuma A, Kinai E, Goto T, Takahashi S, Takeda H, Tanaka T,
Teruya K, Hanai J, Fujii T, Fujitani J, Hosaka T, Mita E,
Minami R, Moro H, Yokomaku Y, Watanabe D,
Watanabe T, Yotsuyanagi H
Non-acquired immunodeficiency syndrome defining malignancies in
people living with haemophilia and human immunodeficiency virus
after direct-acting antiviral era
Glob Health Medicine. 2024;6(5):316-323.
#放射線学 #核医学 #医用画像
Sunaguchi N, Yuasa T, Shimao D, Huang ZR, Ichihara S,
Nishimura R, Iwakoshi A, Kim JK, Gupta R, Ando M
Phase-contrast visualization of human tissues using superimposed
wavefront imaging of diffraction-enhanced x-rays
Med Phys. 2024 AUG 1;
Journal Impact Factor 2021: 4.506
豊橋医療センター
#物質乱用
Oya-Watanabe Y, Inagaki K, Nimi T, Yamamoto Y, Tanabe T, Okai M,
Segawa N, Watanabe T, Uchibori N, Koide T, Inukai J, Yuasa H,
Mitani A, Nagao T, Fukui M, Hinode D
Attitudes toward smoking cessation according to smoking status
among dentists in the Aichi Dental Association in Japan
Tob Induc Dis. 2024 AUG;22
Journal Impact Factor 2021: 5.163
三重病院
#免疫学 #レビュー論文
Sunagawa T, Kobayashi Y, Takashima Y, Kamiya H, Shimada T, Nakashima
K, Arai S, Taniguchi K, Tanaka-Taya K, Okabe N
Using Regular High-Quality Serosurveys to Identify and Close
National Immunity Gaps-Measles and Rubella Elimination in Japan
Vaccines. 2024 AUG;12(8)
Journal Impact Factor 2021: 4.961
#小児科学 #多施設共同研究
Suzuki Y, Nagamitsu S, Eshima N, Inoue T, Otani R, Sakuta R, Iguchi T,
Ishii R, Uchida S, Okada A, Kitayama S, Koyanagi K, Suzuki Y,
Sumi Y, Takamiya S, Fujii C, Fukai Y
Body weight and eating attitudes influence improvement of
depressive symptoms in children and pre-adolescents with eating
disorders: a prospective multicenter cohort study
BMC Pediatr. 2024 AUG 27;24(1)
Journal Impact Factor 2021: 2.567
鈴鹿病院
#臨床神経学 #症例報告
Kuru S, Sakai M, Moriyoshi H, Miyahara H, Iwasaki Y
An autopsy case of progressive supranuclear palsy with severe
corticospinal tract degeneration
Neuropathology. 2024 DEC;44(6):452-458.
Journal Impact Factor 2021: 2.076
あわら病院
#公衆衛生学 #環境衛生学 #労働衛生学
Sakai T, Ueda Y, Yanagisawa H, Arita K, Iwao H, Yamada K, Mizuta S,
Kawabata H, Fukushima T, Tai KTNR, Kishi S, Morinaga K,
Murakami J, Takamatsu H, Terasaki Y, Yoshio N, Kondo Y, Okumura
H, Matano S, Yamaguchi M, Tsutani H, Masaki Y
Prospective therapeutic studies of disseminated extranodal large
B-cell lymphoma including intravascular large B-cell lymphoma
Glob Health Medicine. 2024;6(4):277-281.
京都医療センター
#医学 #研究 #実験
Murata T, Sakane N, Hirota Y, Toyoda M, Matsuhisa M, Kuroda A,
Itoh A, Meguro S, Miura J, Matoba Y, Kato K, Suzuki S, Shimada A
Difference in the accuracy of the third-generation algorithm and
the first-generation algorithm of FreeStyle Libre continuous glucose
monitoring device
J Med Investig. 2024 AUG;71(3-4):225-231.
Journal Impact Factor 2021: N/A
PMID:
39462556 WoS:
WOS:001362302900006
#泌尿器学 #腎臓学 #レビュー論文
Morizane S, Miki J, Shimbo M, Kanno T, Miura N, Yamada Y,
Yamasaki T, Saika T, Takenaka A, A Working Grp Standardization
Japanese expert consensus on the standardization of robot-assisted
pelvic lymph node dissection in urological surgery: Extent of pelvic
lymph node and surgical technique
Int J Urol. 2024 DEC;31(12):1300-1310.
Journal Impact Factor 2021: 2.896
#消化器病学 #肝臓学 #レビュー論文
Sugimoto M, Murata M, Murakami K, Yamaoka Y, Kawai T
Characteristic endoscopic findings in
Helicobacter pylori diagnosis in clinical practice
Expert Rev Gastroenterol Hepatol. 2024 AUG
2;18(8):457-472.
Journal Impact Factor 2021: 4.095
#生化学 #分子生物学
Yaku H, Takahashi K, Okada H, Kobiyama K, Shiokawa M, Uza N,
Kodama Y, Ishii KJ, Seno H
Near-infrared photoimmunotherapy as a complementary modality to in
situ vaccine in a preclinical pancreatic cancer model
Biochem Biophys Res Commun. 2024 DEC 10;737
Journal Impact Factor 2021: 3.322
#放射線学 #核医学 #医用画像
Nakamoto T, Nawa K, Nishiyama K, Yoshida K, Saito D, Horiguchi
M, Shinya Y, Ohta T, Ozaki S, Nozawa Y, Minamitani M, Imae T, Abe O,
Yamashita H, Nakagawa K
Neurological prognosis prediction for cardiac arrest patients using
quantitative imaging biomarkers from brain computed tomography
Phys Medica. 2024 SEP;125
Journal Impact Factor 2021: 3.119
#内分泌学 #新陳代謝
Meguro S, Sakane N, Hosoda K, Hirota Y, Itoh A, Kato K,
Kodani N, Kuroda A, Matsuhisa M, Miura J, Shimada A, Tone A, Toyoda M,
Murata T, ISCHIA Study Grp
Diurnal variation in the association between the scan frequency of
isCGM and CGM metrics: post hoc analysis of the ISCHIA study
Diabetol Int. 2024 OCT;15(4):828-836.
Journal Impact Factor 2021: N/A
#老年医学 #老年学 #多施設共同研究
Nishimura A, Masuda C, Murauchi C, Ishii M, Murata Y, Kawasaki T,
Azuma M, Arai H, Harashima SI
Regional differences in frailty among older adults with type 2
diabetes: a multicenter cross-sectional study in Japan
BMC Geriatr. 2024 AUG 17;24(1)
Journal Impact Factor 2021: 4.07
#公衆衛生学 #環境衛生学 #労働衛生学
Onda M, Horiguchi M, Domichi M, Sakane N
Effect of a Smoking Cessation Education Program on the Knowledge,
Attitude, and Self-Efficacy of Community Pharmacists in Japan: A
Quasi-Experimental Study
Tob Use Insights. 2024 JUL;17
Journal Impact Factor 2021: N/A
#医学 #一般医療 #内科学
Adachi K, Murata M, Inada A, Morimoto T, Shimizu
M, Beppu S, Yamazaki H
Interaction of a caffeine overdose with clinical doses of
contraceptive ethinyl estradiol in a young woman
Acute Med Surg. 2024 JAN;11(1)
Journal Impact Factor 2021: N/A
#腫瘍学
Okamura R, Aoyama R, Tsunoda S, Yamashita Y, Hata H,
Kinjo Y, Miki A, Kanaya S, Yamamoto M, Matsuo K, Manaka D,
Tanaka E, Kawada H, Kondo M, Itami A, Kan T, Kadokawa Y, Ito T,
Jikihara S, Kasahara K, Sakamoto T, Okumura S, Maekawa H, Nishigori T,
Hisamori S, Obama K
Management challenges and the role of adjuvant chemotherapy in
remnant gastric cancer: an analysis of 313 patients from the
KEGG multicenter observational study
Gastric Cancer. 2024 NOV;27(6):1302-1310.
Journal Impact Factor 2021: 7.701
#病理学
Yamada Y, Küffer S, Sauer C, Hoki M, Shibuya S, Tsujii H, Ono K,
Moriyoshi K, Date H, Yoshizawa A, Szolkowska M, Haga H, Ströbel
P, Marx A
Immunohistochemistry for YAP1 N-terminus and C-terminus highlights
metaplastic thymoma and high-grade thymic epithelial tumors by
different staining patterns
Virchows Arch. 2024 SEP;485(3):461-469.
Journal Impact Factor 2021: 4.548
#公衆衛生学 #環境衛生学 #労働衛生学
Sakai T, Ueda Y, Yanagisawa H, Arita K, Iwao H, Yamada K, Mizuta S,
Kawabata H, Fukushima T, Tai KTNR, Kishi S, Morinaga K,
Murakami J, Takamatsu H, Terasaki Y, Yoshio N, Kondo Y, Okumura
H, Matano S, Yamaguchi M, Tsutani H, Masaki Y
Prospective therapeutic studies of disseminated extranodal large
B-cell lymphoma including intravascular large B-cell lymphoma
Glob Health Medicine. 2024;6(4):277-281.
#歯科学 #口腔外科 #口腔内科
Yoshida K
Peripherally induced movement disorders in the stomatognathic
system after oral surgical or dental procedures
Oral Maxillofac Surg-Heidelb. 2024 DEC;28(4):1579-1586.
Journal Impact Factor 2021: N/A
宇多野病院
#臨床神経学 #レビュー論文
Niino M, Isobe N, Araki M, Ohashi T, Okamoto T, Ogino M, Okuno
T, Ochi H, Kawachi I, Shimizu Y, Takahashi K, Takeuchi H,
Tahara M, Chihara N, Nakashima I, Fukaura H, Misu T,
Miyazaki Y, Miyamoto K, Mori M, Kinoshita M, Takai Y, Fujii C,
Watanabe M, Fujihara K
Clinical practice guidelines for multiple sclerosis, neuromyelitis
optica spectrum disorder, and myelin oligodendrocyte glycoprotein
antibody-associated disease 2023 in Japan
Mult Scler Relat Disord. 2024 OCT;90
Journal Impact Factor 2021: 4.808
#臨床神経学 #症例報告
Ohara H, Kikutsuji N, Iguchi N, Kinoshita M
Efgartigimod combined with steroids as a fast-acting therapy for
myasthenic crisis: a case report
BMC Neurol. 2024 AUG 22;24(1)
Journal Impact Factor 2021: 2.903
舞鶴医療センター
#ヘルスケア科学 #サービス #プロトコル論文
#ランダム化比較試験
Imai A, Matsuoka T, Nakayam C, Hashimo N, Sano M, Narumoto J
Effectiveness of a Virtual Reality Open-Air Bath Program inReducing
Loneliness and Improving Brain Function for DementiaPrevention in
Older Adults:Protocol for a Prospective RandomizedCrossover Study
JMIR RES Protoc. 2024;13
Journal Impact Factor 2021: N/A
大阪医療センター
#腫瘍学 #第II相試験 #多施設共同研究 #ランダム化比較試験
Raghav K, Siena S, Takashima A, Kato T, van den Eynde M,
Pietrantonio F, Komatsu Y, Kawakami H, Peeters M, Andre T, Lonardi S,
Yamaguchi K, Tie JN, Castro CG, Hsu HC, Strickler JH, Kim TY, Cha YJ,
Barrios D, Yan Q, Kamio T, Kobayashi K, Boran A, Koga M, Allard J,
Yoshino T
Trastuzumab deruxtecan in patients with HER2-positive advanced
colorectal cancer (DESTINY-CRC02): primary results from a
multicentre, randomised, phase 2 trial
Lancet Oncol. 2024 SEP;25(9)
Journal Impact Factor 2021: 54.433
#腫瘍学
Yamamoto Y, Yukami H, Yamaguchi T, Ohori H, Nagasu S, Kagawa Y,
Sugimoto N, Sonoda H, Yamazaki K, Takashima A, Okuyama H,
Hasegawa H, Kondo C, Baba E, Matsumoto T, Kawamoto Y,
Kataoka M, Shindo Y, Ishikawa T, Esaki T, Kito Y, Sato
T, Funakoshi T, Yamaguchi T, Shimada Y, Moriwaki T
Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with
metastatic colorectal cancer: the JSCCR-TRIPON study
Int J Clin Oncol. 2024 AUG 28;
Journal Impact Factor 2021: 3.85
#腫瘍学
Sudo K, Nakamura Y, Ueno M, Furukawa M, Mizuno N, Kawamoto Y,
Okano N, Umemoto K, Asagi A, Ozaka M, Ohtsubo K, Shimizu S,
Matsuhashi N, Itoh S, Matsumoto T, Satoh T, Okuyama H, Goto M,
Hasegawa H, Yamamoto Y, Odegaard JI, Bando H, Yoshino T, Ikeda
M, Morizane C
Clinical utility of BRCA and ATM mutation status in
circulating tumour DNA for treatment selection in advanced
pancreatic cancer
Br J Cancer. 2024 OCT 19;131(7):1158-1168.
Journal Impact Factor 2021: 9.082
#複合科学 #症例報告
Watanabe D, Okamoto N, Kobayashi Y, Suzuki H, Kato M, Saitoh S,
Kanemura Y, Takenouchi T, Yamada M, Nakato D, Sato M, Tsunoda
T, Kosaki K, Miya F
Biallelic structural variants in three patients with ERCC8-related
Cockayne syndrome and a potential pitfall of copy number variation
analysis
Sci Rep. 2024 AUG 26;14(1)
Journal Impact Factor 2021: 4.997
#皮膚病学 #症例報告
Hiraki T, Mori H, Misawa J, Yunoki M, Goto K
NRASQ61R-driven atypical melanocytic tumor with
blue nevus-like morphology: A case report
J Cutan Pathol. 2024 DEC;51(12):948-953.
Journal Impact Factor 2021: 1.458
#消化器病学 #肝臓学 #多施設共同研究 #第II相試験
#ランダム化比較試験
Hori S, Yamasaki M, Yamamoto N, Harino T, Momose K, Yamashita K,
Tanaka K, Sugimura K, Makino T, Takeno A, Shiraishi O, Motoori
M, Miyata H, Kimura Y, Hirao M, Yasuda T, Yano M, Doki Y
The impact of time to postoperative recurrence on the prognosis of
patients with esophageal cancer post recurrence: exploratory
analysis of OGSG 1003
Esophagus. 2024 OCT;21(4):472-483.
Journal Impact Factor 2021: 3.671
#腫瘍学
Noguchi E, Yamanaka T, Mukai H, Yamamoto N, Chung CF, Lu YS, Chang DY,
Sohn J, Kim GM, Lee KH, Lee SC, Iwasa T, Iwata H, Watanabe K,
Jung KH, Tanabe Y, Kang SY, Yasojima H, Aogi K,
Tokunaga E, Sim SH, Yap YS, Matsumoto K, Tseng LM, Umeyama Y,
Sudo K, Kojima Y, Hata T, Kuchiba A, Shibata T, Nakamura K, Fujiwara
Y, Tamura K, Yonemori K
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients
with HR-positive/HER2-negative advanced breast cancer
npj Breast Cancer. 2024 AUG 22;10(1)
Journal Impact Factor 2021: 7.519
#血液学
Shimazu Y, Kanda J, Takakuwa T, Onda Y, Fukushima K, Hotta M, Fuchida
SI, Uoshima N, Shimura Y, Tanaka H, Ohta K, Shibayama H, Kosugi
S, Yagi H, Yoshihara S, Hosen N, Ito T, Shimazaki C, Matsumura I,
Kuroda J, Takaori-Kondo A, Hino M
The impact of renal function on initial therapy in
transplant-ineligible multiple myeloma patients
Ann Hematol. 2024 AUG 21;
Journal Impact Factor 2021: 4.03
#腫瘍学
Kusunoki C, Uemura M, Osaki M, Takiguchi N, Kitakaze M, Paku M, Sekido
Y, Takeda M, Hata T, Hamabe A, Ogino T, Miyoshi N, Tei M, Kagawa Y,
Kato T, Eguchi H, Doki Y
Postoperative venous thromboembolism after surgery for locally
recurrent rectal cancer
BMC Cancer. 2024 AUG 20;24(1)
Journal Impact Factor 2021: 4.638
#内分泌学 #新陳代謝
Meguro S, Sakane N, Hosoda K, Hirota Y, Itoh A, Kato K,
Kodani N, Kuroda A, Matsuhisa M, Miura J, Shimada A, Tone A, Toyoda M,
Murata T, ISCHIA Study Grp
Diurnal variation in the association between the scan frequency of
isCGM and CGM metrics: post hoc analysis of the ISCHIA study
Diabetol Int. 2024 OCT;15(4):828-836.
Journal Impact Factor 2021: N/A
#臨床神経学
Peacock M, Drumm B, Klein P, Raymond J, Huo XC, Chen YM, Abdalkader M,
Schonewille WJ, Liu XF, Hu W, Li CH, Ji XM, Alemseged F, Liu LP,
Siegler JE, Nagel S, Strbian D, Sacco S, Yaghi S, Qureshi MM, Fischer
U, de Sousa DA, Yamagami H, Michel P, Puetz V, Mujanovic A,
Marto JP, Kristoffersen ES, Sandset EC, Demeestere J, Hanning U,
Novakovic R, Kenmuir C, Agid R, Romoli M, Diana F, Lobotesis K, Roi D,
Masoud HE, Ma ALC, Zhu YY, Sang HF, Sun DP, Ton MD, Li FL, Nasreldein
A, Jesser J, Kaesmacher J, Weyland CS, Meyer L, Yeo LLL, Yang QW,
Thomalla G, Yang PF, Poli S, Campbell BCV, Qureshi AI, Chen HS, Zaidat
OO, Qiu ZM, Nogueira RG, Jovin TG, Miao ZR, Nguyen TN, Banerjee S
Basilar artery occlusion management: An international survey of
gender influence on management
Interv Neuroradiol. 2024 AUG 14;
Journal Impact Factor 2021: 1.764
#公衆衛生学 #環境衛生学 #労働衛生学
Koga M, Fukuda A, Nojima M, Ishizaka A, Itoh T, Eguchi S, Endo
T, Kakinuma A, Kinai E, Goto T, Takahashi S, Takeda H, Tanaka T,
Teruya K, Hanai J, Fujii T, Fujitani J, Hosaka T, Mita E,
Minami R, Moro H, Yokomaku Y, Watanabe D,
Watanabe T, Yotsuyanagi H
Non-acquired immunodeficiency syndrome defining malignancies in
people living with haemophilia and human immunodeficiency virus
after direct-acting antiviral era
Glob Health Medicine. 2024;6(5):316-323.
#腫瘍学
Ueda H, Takahashi H, Akita H, Tomimaru Y, Kobayashi S, Kubo M, Mukai
Y, Toshiyama R, Sasaki K, Hasegawa S, Iwagami Y,
Sakai K, Yamada D, Noda T, Asaoka T, Wada H, Gotoh K,
Doki Y, Eguchi H
Prognostic impact of aberrant right hepatic artery involvement in
patients with pancreatic cancer: A multicenter retrospective cohort
study
J Surg Oncol. 2024 SEP;130(3):504-515.
Journal Impact Factor 2021: 2.885
#医学 #一般医療 #内科学 #症例報告
Nobe R, Ishida K, Togami Y, Ojima M,
Sogabe T, Ohnishi M
Improving oxygenation in a patient with respiratory failure due to
morbid obesity by applying airway pressure release ventilation: a
case report
J Med Case Rep. 2024 AUG 5;18(1)
近畿中央呼吸器センター
#呼吸器系
Shimoda M, Tanaka Y, Ohe T, Ishiguro T, Suzuki A, Kurahara Y,
Shimatani Y, Matsushima H, Kusano K, Ohta H, Yanagisawa S, Kozu
Y, Yui T, Igarashi S, Kimizuka Y, Honda K, Otani S, Chiba S, Xu DJ,
Mitsui M, Waseda Y, Ishii H
Validation of a diagnostic flowchart for tuberculous pleurisy in
pleural fluid with high levels of adenosine deaminase
Respir Investig. 2024 NOV;62(6):963-969.
Journal Impact Factor 2021: N/A
#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D,
Isa SI, Nakamura K, Mizumori Y,
Shinohara T, Yanai H, Nakatomi K, Oki M,
Mori M, Kuwako T, Yamazaki K, Tamura A,
Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib
treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC
based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32
#複合科学
Yaga M, Hasegawa K, Ikeda S, Matsubara M, Hiroshima T, Kimura T,
Shirai Y, Tansri W, Uehara H, Tachikawa M, Okairi Y, Sone M, Mori H,
Kogue Y, Akamine H, Okuzaki D, Kawagishi K, Kawanaka S,
Yamato H, Takeuchi Y, Okura E, Kanzaki R, Okami J,
Nakamichi I, Nakane S, Kobayashi A, Iwazawa T, Tokunaga T,
Yokouchi H, Yano Y, Uchida J, Mori M, Komuta K,
Tachi T, Kuroda H, Kijima N, Kishima H, Ichii M, Futami S, Naito Y,
Shiroyama T, Miyake K, Koyama S, Hirata H, Takeda Y, Funaki S,
Shintani Y, Kumanogoh A, Hosen N
CD98 heavy chain protein is overexpressed in non-small cell lung
cancer and is a potential target for CAR T-cell therapy
Sci Rep. 2024 AUG 2;14(1)
Journal Impact Factor 2021: 4.997
#腫瘍学
Morimoto K, Hamashima R, Yamada T, Yokoyama T, Kobayashi T,
Tsuyuguchi K, Kanematsu T, Tamiya N, Tsuji T, Nakamura R,
Katayama Y, Nishioka N, Iwasaku M, Tokuda S, Takayama K
Clinical significance of chronic pulmonary aspergillosis in lung
cancer patients undergoing anticancer drug therapy
Thorac Cancer. 2024 SEP;15(26):1882-1888.
Journal Impact Factor 2021: 3.223
大阪刀根山医療センター
#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D,
Isa SI, Nakamura K, Mizumori Y,
Shinohara T, Yanai H, Nakatomi K, Oki M,
Mori M, Kuwako T, Yamazaki K, Tamura A,
Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib
treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC
based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32
#複合科学
Yaga M, Hasegawa K, Ikeda S, Matsubara M, Hiroshima T, Kimura T,
Shirai Y, Tansri W, Uehara H, Tachikawa M, Okairi Y, Sone M, Mori H,
Kogue Y, Akamine H, Okuzaki D, Kawagishi K, Kawanaka S,
Yamato H, Takeuchi Y, Okura E, Kanzaki R, Okami J,
Nakamichi I, Nakane S, Kobayashi A, Iwazawa T, Tokunaga T,
Yokouchi H, Yano Y, Uchida J, Mori M, Komuta K,
Tachi T, Kuroda H, Kijima N, Kishima H, Ichii M, Futami S, Naito Y,
Shiroyama T, Miyake K, Koyama S, Hirata H, Takeda Y, Funaki S,
Shintani Y, Kumanogoh A, Hosen N
CD98 heavy chain protein is overexpressed in non-small cell lung
cancer and is a potential target for CAR T-cell therapy
Sci Rep. 2024 AUG 2;14(1)
Journal Impact Factor 2021: 4.997
#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y,
Nakamura K, Mizumori Y, Shinohara T,
Yanai H, Nakatomi K, Oki M, Mori M,
Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment
co-alterations and p-prognosis to osimertinib in chemo-naïve
advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081
大阪南医療センター
#臨床神経学
Kamatani T, Kitaguchi K, Kashii M
Characteristics in patients with very early therapeutic response of
condoliase chemonucleolysis for lumbar disc herniation
Neurosurg Rev. 2024 AUG 13;47(1)
Journal Impact Factor 2021: 2.8
姫路医療センター
#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D,
Isa SI, Nakamura K, Mizumori Y,
Shinohara T, Yanai H, Nakatomi K, Oki M,
Mori M, Kuwako T, Yamazaki K, Tamura A,
Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib
treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC
based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32
#リウマチ学
Higuchi T, Oka S, Shimada K, Tsunoda S, Ito S,
Okamoto A, Fujimori M, Nakamura T, Katayama M,
Suzuki M, Saisho K, Shinohara S, Matsui T,
Migita K, Nagaoka S, Tohma S, Furukawa H
Association of rare single-nucleotide variant MUC5B rs35705950 with
interstitial lung disease in Japanese rheumatoid arthritis
RHEUMATOLOGY. 2024 AUG 19;
Journal Impact Factor 2021: 7.046
#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y,
Nakamura K, Mizumori Y, Shinohara T,
Yanai H, Nakatomi K, Oki M, Mori M,
Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment
co-alterations and p-prognosis to osimertinib in chemo-naïve
advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081
#腫瘍学
Okamura R, Aoyama R, Tsunoda S, Yamashita Y, Hata H,
Kinjo Y, Miki A, Kanaya S, Yamamoto M, Matsuo K, Manaka D,
Tanaka E, Kawada H, Kondo M, Itami A, Kan T, Kadokawa Y, Ito T,
Jikihara S, Kasahara K, Sakamoto T, Okumura S, Maekawa H, Nishigori T,
Hisamori S, Obama K
Management challenges and the role of adjuvant chemotherapy in
remnant gastric cancer: an analysis of 313 patients from the
KEGG multicenter observational study
Gastric Cancer. 2024 NOV;27(6):1302-1310.
Journal Impact Factor 2021: 7.701
兵庫中央病院
#神経科学
Noda Y, Sekiguchi K, Matoba S, Suehiro H, Nishida K, Matsumoto
R
Real-time artificial intelligence-based texture analysis of muscle
ultrasound data for neuromuscular disorder assessment
Clin Neurophys Pract. 2024;9:242-248.
Journal Impact Factor 2021: N/A
和歌山病院
#呼吸器系
Minakata Y, Sasaki S, Murakami Y,
Kawabe K, Ono H
Processing of Sedentary Time and Its Reference Equation in Patients
with COPD
Int J Chronic Obstr Pulm Dis. 2024;19:1931-1942.
Journal Impact Factor 2021: 2.893
米子医療センター
#医学 #研究 #実験 #症例報告
Oshima Y, Tanaka A, Fukuki M, Otsuki A,
Hisatome I
A Case of High-Dose Intravenous MgSO4 and Hemoperfusion for Aconite
Poisoning with Chronic Kidney Disease
Yonago Acta Med. 2024 AUG;67(3):270-279.
Journal Impact Factor 2021: 1.371
#泌尿器学 #腎臓学
Yamane H, Morizane S, Honda M, Muraoka K, Oono H, Isoyama T,
Ono K, Sejima T, Kadowaki H, Takenaka A
Preoperative risk stratification models after radical cystectomy
for bladder cancer: A multi-center study
Int J Urol. 2024 NOV;31(11):1278-1287.
Journal Impact Factor 2021: 2.896
岡山医療センター
#心臓 #循環器系 #症例報告
Monden Y, Une D, Furuta M, Yoshida K,
Nakai M
Transatrial repair of a giant left ventricular pseudoaneurysm and
ischaemic mitral regurgitation after myocardial infarction: case
report
Eur Heart J-Case Rep. 2024 AUG 16;8(8)
Journal Impact Factor 2021: N/A
#小児科学 #症例報告
Fujiwara S, Higuchi Y, Furujo M, Goda M,
Takigawa Y, Sato K, Hitomi K, Mukai W,
Oiwa M
Seven-year-old boy with severe dyspnoea and influenza virus
infection
J Paediatr Child Health. 2024 OCT;60(10):619-620.
Journal Impact Factor 2021: 1.929
#呼吸器系 #症例報告
Fujiwara M, Watanabe H, Takigawa Y,
Goda M, Shiraha K, Inoue T, Matsuoka S,
Kudo K, Sato A, Sato K, Fujiwara K,
Shibayama T
Successful treatment of type B2 thymoma with steroid and
radiotherapy
Respirol Case Rep. 2024 AUG;12(8)
Journal Impact Factor 2021: N/A
呉医療センター
#消化器病学 #肝臓学
Shibata Y, Sudo T, Tazuma S, Tanimine N,
Onoe T, Shimizu Y, Yamaguchi A, Kuraoka K,
Takahashi S, Tashiro H
Transmembrane serine protease 4 expression in the prognosis of
radical resection for biliary tract cancer
World J Gastrointest Surg. 2024 AUG 27;16(8)
Journal Impact Factor 2021: 2.505
#外科学 #症例報告
Fujii T, Onoe T, Tanimine N, Shimizu Y,
Tashiro H
Treatment of intractable isolated bile leakage occurring after
right anterior sectionectomy for hepatocellular carcinoma: Right
hepatico-jejunostomy
Int J Surg Case Rep. 2024 OCT;123
Journal Impact Factor 2021: N/A
#腫瘍学
Iwatani T, Sasaki K, Machida R, Shien T, Hara F, Fujisawa T, Takano Y,
Kobayashi Y, Saimura M, Koizumi K, Terada M, Sasada S, Saito K,
Sumiyoshi M, Iwata H
Status of incremental costs of first-line treatment recommended in
Japanese clinical guidelines for metastatic breast cancer
patients
Jpn J Clin Oncol. 2024 AUG 23;54(10):1093-1099.
Journal Impact Factor 2021: 2.925
#消化器病学 #肝臓学
Tanino F, Yamashita K, Nagata S, Kuwai T, Kamigaichi Y, Tanaka
H, Tamaru Y, Takigawa H, Asayama N, Urabe Y, Shimamoto F, Oka S
Vertical margin distance in T1 colorectal carcinoma resected by
endoscopic submucosal dissection affects prognosis after additional
surgery
Int J Colorectal Dis. 2024 AUG 16;39(1)
Journal Impact Factor 2021: 2.796
#腫瘍学 #観察研究
Sunakawa Y, Sakamoto Y, Kawabata R, Ishiguro A, Akamaru Y, Kito Y,
Takahashi M, Matsuyama J, Yabusaki H, Makiyama A, Suzuki T,
Tsuda M, Yasui H, Hihara J, Takeno A, Inoue E, Ichikawa W, Fujii M
Tumor Response Predicts Survival Time of Nivolumab Monotherapy for
Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial
(JACCRO GC-08)
Oncologist. 2024 APR 6;29(8):e997-e1002.
Journal Impact Factor 2021: 5.837
福山医療センター
#医学 #一般医療 #内科学 #症例報告
Tsukada R, Iwasaki S, Ibuka S, Saka R
Littre's Hernia Incidentally Found During Laparoscopic Indirect
Inguinal Hernia Repair in a Child
Cureus J Med Sci. 2024 AUG 9;16(8)
Journal Impact Factor 2021: N/A
山口宇部医療センター
#腫瘍学 #第II相試験 #多施設共同研究
Yoh K, Azuma K, Hayashi H, Nishio M, Chikamori K, Ichihara E,
Watanabe Y, Asato T, Kitagawa T, Fram RJ, Ohe Y
A phase 2 study of mobocertinib as first-line treatment in Japanese
patients with non-small cell lung cancer harboring EGFR exon
20 insertion mutations
Int J Clin Oncol. 2024 OCT;29(10):1461-1474.
Journal Impact Factor 2021: 3.85
岩国医療センター
#呼吸器系 #プロトコル論文
Nakamura N, Makimoto G, Tanaka T, Kato Y, Oze I,
Kozuki T, Yokoyama T, Ichikawa H, Kuyama S, Hara N,
Maeda Y, Hotta K
A randomized, open-label phase II study on the preventive effect of
goshajinkigan against peripheral neuropathy induced by
paclitaxel-containing chemotherapy: The OLCSG2101 study protocol
Respir Investig. 2024 SEP;62(5):897-900.
Journal Impact Factor 2021: N/A
四国がんセンター
#医学 #研究 #実験 #多施設共同研究
Sugihara N, Hashine K, Yamashita N, Sakamoto M,
Terashita M, Funaki K, Saiki K, Sawada T, Kakuda T, Nishimura K,
Fukumoto T, Miura N, Miyauchi Y, Kikugawa T, Saika T
Can Pelvic Lymph Node Dissection in Prostate Cancer Patients with a
5% Briganti Nomogram Cut-off Value Provide an Oncological Benefit? A
Large Multi-Institutional Cohort Study in Japan
Acta Med Okayama. 2024 AUG;78(4):307-312.
Journal Impact Factor 2021: 0.744
PMID:
39198984 WoS:
WOS:001310576400001
#腫瘍学 #第III相試験 #ランダム化比較試験 #多施設共同研究
Colombo N, Biagioli E, Harano K, Galli F, Hudson E, Antill Y, Choi CH,
Rabaglio M, Marmé F, Marth C, Parma G, Fariñas-Madrid L, Nishio S,
Allan K, Lee YC, Piovano E, Pardo B, Nakagawa S, Mcqueen J, Zamagni C,
Manso L, Takehara K, Tasca G, Ferrero A, Tognon G, Lissoni AA,
Petrella M, Laudani ME, Rulli E, Uggeri S, Ginesta MPB, AtTEnd Study
Grp
Atezolizumab and chemotherapy for advanced or recurrent endometrial
cancer (AtTEnd): a randomised, double-blind, placebo-controlled,
phase 3 trial
Lancet Oncol. 2024 SEP;25(9):1135-1146.
Journal Impact Factor 2021: 54.433
#腫瘍学 #第II相試験 #多施設共同研究
Honma Y, Monden N, Yamazaki K, Kano S, Satake H, Kadowaki S,
Utsumi Y, Nakatogawa T, Takano R, Fujii K, Koroki Y, Aoyama J, Ouchi
S, Ogawa T, Mccarthy S, Brookman-May SD, Mundle S, Li JH, Thaper D,
Nagao T, Tada Y
Apalutamide and Goserelin for Androgen Receptor-Positive Salivary
Gland Carcinoma: A Phase II Nonrandomized Clinical Trial,
YATAGARASU
Clin Cancer Res. 2024 AUG 15;30(16):3416-3427.
Journal Impact Factor 2021: 13.801
#腫瘍学
Sudo K, Nakamura Y, Ueno M, Furukawa M, Mizuno N, Kawamoto Y,
Okano N, Umemoto K, Asagi A, Ozaka M, Ohtsubo K, Shimizu S,
Matsuhashi N, Itoh S, Matsumoto T, Satoh T, Okuyama H, Goto M,
Hasegawa H, Yamamoto Y, Odegaard JI, Bando H, Yoshino T, Ikeda
M, Morizane C
Clinical utility of BRCA and ATM mutation status in
circulating tumour DNA for treatment selection in advanced
pancreatic cancer
Br J Cancer. 2024 OCT 19;131(7):1158-1168.
Journal Impact Factor 2021: 9.082
#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D,
Isa SI, Nakamura K, Mizumori Y,
Shinohara T, Yanai H, Nakatomi K, Oki M,
Mori M, Kuwako T, Yamazaki K, Tamura A,
Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib
treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC
based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32
#腫瘍学
Nishina T, Boku N, Kurokawa Y, Sasaki K, Machida R, Yoshikawa T
A real-world survey on expensive drugs used as first-line
chemotherapy in patients with HER2-negative unresectable
advanced/recurrent gastric cancer in the stomach cancer study group
of the Japan clinical oncology group
Jpn J Clin Oncol. 2024 AUG 24;54(10):1100-1106.
Journal Impact Factor 2021: 2.925
#呼吸器系 #プロトコル論文
Nakamura N, Makimoto G, Tanaka T, Kato Y, Oze I,
Kozuki T, Yokoyama T, Ichikawa H, Kuyama S, Hara N,
Maeda Y, Hotta K
A randomized, open-label phase II study on the preventive effect of
goshajinkigan against peripheral neuropathy induced by
paclitaxel-containing chemotherapy: The OLCSG2101 study protocol
Respir Investig. 2024 SEP;62(5):897-900.
Journal Impact Factor 2021: N/A
#腫瘍学 #多施設共同研究
Shimizu H, Kodaira T, Kiyota N, Hayashi R, Nishino H, Asada Y, Mitani
H, Hirayama Y, Onozawa Y, Nishio N, Hanai N, Ohkoshi A, Hara H,
Monden N, Nagaoka M, Minami S, Fujii T, Tanaka K, Homma
A, Yoshimoto S, Oridate N, Omori K, Ueda T, Okami K, Uemura H, Shiga
K, Nakahira M, Asakage T, Saito Y, Sasaki K, Kitabayashi R, Ishikura
S, Nishimura Y, Tahara M
Incidence and risk factors associated with the development of
hypothyroidism after postoperative chemoradiotherapy for head and
neck cancer patients with high-risk features: Supplementary analysis
of JCOG1008
Oral Oncol. 2024 OCT;157
Journal Impact Factor 2021: 5.972
#腫瘍学
Noguchi E, Yamanaka T, Mukai H, Yamamoto N, Chung CF, Lu YS, Chang DY,
Sohn J, Kim GM, Lee KH, Lee SC, Iwasa T, Iwata H, Watanabe K,
Jung KH, Tanabe Y, Kang SY, Yasojima H, Aogi K,
Tokunaga E, Sim SH, Yap YS, Matsumoto K, Tseng LM, Umeyama Y,
Sudo K, Kojima Y, Hata T, Kuchiba A, Shibata T, Nakamura K, Fujiwara
Y, Tamura K, Yonemori K
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients
with HR-positive/HER2-negative advanced breast cancer
npj Breast Cancer. 2024 AUG 22;10(1)
Journal Impact Factor 2021: 7.519
#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y,
Nakamura K, Mizumori Y, Shinohara T,
Yanai H, Nakatomi K, Oki M, Mori M,
Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment
co-alterations and p-prognosis to osimertinib in chemo-naïve
advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081
#消化器病学 #肝臓学
Tsuji S, Doyama H, Kobayashi N, Ohata K, Takeuchi Y, Chino A, Takamaru
H, Tsuji Y, Hotta K, Harada K, Ikematsu H, Uraoka T, Murakami T,
Katagiri A, Hori S, Michida T, Suzuki T, Fukuzawa M, Kiriyama
S, Fukase K, Murakami Y, Ishikawa H, Saito Y
Outcomes of noncurative endoscopic submucosal dissection for T1
colorectal cancer: Prospective, multicenter, cohort study in
Japan
Dig Endosc. 2024 DEC;36(12):1369-1379.
Journal Impact Factor 2021: 6.337
#腫瘍学 #多施設共同研究 #観察研究
Kato T, Hirama H, Kamoto T, Goto T, Fujimoto H, Sakamoto S, Shinohara
N, Egawa S, Kouguchi D, Nakayama M, Hashine K, Shimizu N, Inoue
K, Habuchi T, Hioka T, Shiraishi T, Sugimoto M, Kakehi Y
Long-term outcomes of the first prospective study of active
surveillance for prostate cancer in Japan
Int J Clin Oncol. 2024 OCT;29(10):1557-1563.
Journal Impact Factor 2021: 3.85
高知病院
#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D,
Isa SI, Nakamura K, Mizumori Y,
Shinohara T, Yanai H, Nakatomi K, Oki M,
Mori M, Kuwako T, Yamazaki K, Tamura A,
Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib
treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC
based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32
#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y,
Nakamura K, Mizumori Y, Shinohara T,
Yanai H, Nakatomi K, Oki M, Mori M,
Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment
co-alterations and p-prognosis to osimertinib in chemo-naïve
advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081
九州がんセンター
#腫瘍学
Minato A, Furubayashi N, Tomoda T, Masaoka H, Song Y,
Hori Y, Kiyoshima K, Negishi T, Kuroiwa K, Seki
N, Tomisaki I, Nakamura M, Harada K, Fujimoto N
Clinical Outcomes of Enfortumab Vedotin in Advanced Urothelial
Carcinoma With Prior Avelumab Versus Pembrolizumab Therapy
Anticancer Res. 2024 AUG;44(8):3419-3426.
Journal Impact Factor 2021: 2.435
#腫瘍学
Furubayashi N, Minato A, Tomoda T, Masaoka H, Hori Y,
Kiyoshima K, Negishi T, Haraguchi Y, Koga T, Song
YHY, Harada K, Kuroiwa K, Seki N, Fujimoto N,
Nakamura M, Uro-Oncology Grp Kyushu UROKYU
Enfortumab Vedotin for Elderly Advanced Urothelial Carcinoma
Patients or Those With a Poor Performance Status
Anticancer Res. 2024 AUG;44(8):3409-3417.
Journal Impact Factor 2021: 2.435
#腫瘍学
Yamamoto Y, Yukami H, Yamaguchi T, Ohori H, Nagasu S, Kagawa Y,
Sugimoto N, Sonoda H, Yamazaki K, Takashima A, Okuyama H,
Hasegawa H, Kondo C, Baba E, Matsumoto T, Kawamoto Y,
Kataoka M, Shindo Y, Ishikawa T, Esaki T, Kito Y, Sato
T, Funakoshi T, Yamaguchi T, Shimada Y, Moriwaki T
Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with
metastatic colorectal cancer: the JSCCR-TRIPON study
Int J Clin Oncol. 2024 AUG 28;
Journal Impact Factor 2021: 3.85
#腫瘍学
Sudo K, Nakamura Y, Ueno M, Furukawa M, Mizuno N, Kawamoto Y,
Okano N, Umemoto K, Asagi A, Ozaka M, Ohtsubo K, Shimizu S,
Matsuhashi N, Itoh S, Matsumoto T, Satoh T, Okuyama H, Goto M,
Hasegawa H, Yamamoto Y, Odegaard JI, Bando H, Yoshino T, Ikeda
M, Morizane C
Clinical utility of BRCA and ATM mutation status in
circulating tumour DNA for treatment selection in advanced
pancreatic cancer
Br J Cancer. 2024 OCT 19;131(7):1158-1168.
Journal Impact Factor 2021: 9.082
#外科学
Iseda N, Itoh S, Toshima T, Yoshiya S, Bekki Y, Tsutsui Y, Toshida K,
Inokuchi S, Utsunomiya T, Tomino T, Sugimachi K, Morita
K, Ninomiya M, Harada N, Minagawa R, Yoshizumi T
Outcome of hepatectomy after systemic therapy for hepatocellular
carcinoma: a Japanese multicenter study
Surg Today. 2024 AUG 27;
Journal Impact Factor 2021: 2.54
#腫瘍学
Noguchi E, Yamanaka T, Mukai H, Yamamoto N, Chung CF, Lu YS, Chang DY,
Sohn J, Kim GM, Lee KH, Lee SC, Iwasa T, Iwata H, Watanabe K,
Jung KH, Tanabe Y, Kang SY, Yasojima H, Aogi K,
Tokunaga E, Sim SH, Yap YS, Matsumoto K, Tseng LM, Umeyama Y,
Sudo K, Kojima Y, Hata T, Kuchiba A, Shibata T, Nakamura K, Fujiwara
Y, Tamura K, Yonemori K
A phase 3 study (PATHWAY) of palbociclib plus tamoxifen in patients
with HR-positive/HER2-negative advanced breast cancer
npj Breast Cancer. 2024 AUG 22;10(1)
Journal Impact Factor 2021: 7.519
#消化器病学 #肝臓学 #多施設共同研究
Okamura A, Watanabe M, Okui J, Kuriyama K, Shiraishi O, Kurogochi T,
Abe T, Sato H, Miyata H, Kawaguchi Y, Sato Y, Nagano H, Takeno S,
Nakajima M, Matsuo K, Murakami K, Takebayashi K, Matsumoto S, Okumura
T, Kakeji Y, Kono K, Oridate N, Toh Y, Takeuchi H, Katori Y,
Joint Res Japan Bronchoesophagological Soc Japan Esophageal Soc
Esophagectomy for esophageal cancer in patients with a history of
total pharyngolaryngectomy: a Japanese nationwide retrospective
cohort study
Esophagus. 2024 OCT;21(4):438-446.
Journal Impact Factor 2021: 3.671
#腫瘍学
Muto Y, Kambayashi Y, Kato H, Mizuhashi S, Ito T, Maekawa T, Ishizuki
S, Uchi H,
Matsushita S, Yamamoto Y, Yoshino K, Fujisawa Y, Amagai R, Ohuchi K, Hashimoto A,
Fukushima S, Asano Y, Fujimura T
Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma
including Acral and Mucosal Subtypes
Cancers. 2024 AUG;16(15)
Journal Impact Factor 2021: 6.575
#免疫学
Nakashima K, Imai T, Shiraishi A, Unose R, Goto H, Nagatomo Y,
Kojima-Ishii K, Mushimoto Y, Nishiyama K, Yamamura K, Nagata H,
Ishimura M, Kusuhara K, Koga Y, Sakai Y, Ohga S
The immunoreactive signature of monocyte-derived dendritic cells
from patients with Down syndrome
Clin Exp Immunol. 2024 JUN 28;217(3):291-299.
Journal Impact Factor 2021: 5.732
九州医療センター
#臨床神経学
Ohata K, Arai H, Ezura M, Iihara K, Kinouchi H, Kobayashi S,
Tominaga T, Minematsu K, Murayama Y, Nakayama N, Sakai N,
Yasaka M, Yoshimoto Y, Kobayashi S
Nationwide All-case Survey on the Efficacy and Safety of Flow
Diverter: Multicenter Study Conducted by the Japan Neurosurgical
Society
Neurol Med-Chir. 2024 AUG;64:1-106.
Journal Impact Factor 2021: 2.036
#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D,
Isa SI, Nakamura K, Mizumori Y,
Shinohara T, Yanai H, Nakatomi K, Oki M,
Mori M, Kuwako T, Yamazaki K, Tamura A,
Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib
treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC
based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32
#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y,
Nakamura K, Mizumori Y, Shinohara T,
Yanai H, Nakatomi K, Oki M, Mori M,
Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment
co-alterations and p-prognosis to osimertinib in chemo-naïve
advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081
#公衆衛生学 #環境衛生学 #労働衛生学
Koga M, Fukuda A, Nojima M, Ishizaka A, Itoh T, Eguchi S, Endo
T, Kakinuma A, Kinai E, Goto T, Takahashi S, Takeda H, Tanaka T,
Teruya K, Hanai J, Fujii T, Fujitani J, Hosaka T, Mita E,
Minami R, Moro H, Yokomaku Y, Watanabe D,
Watanabe T, Yotsuyanagi H
Non-acquired immunodeficiency syndrome defining malignancies in
people living with haemophilia and human immunodeficiency virus
after direct-acting antiviral era
Glob Health Medicine. 2024;6(5):316-323.
#心臓 #循環器系
Yasaka M, Shimizu F, Niwa Y, Kiyonaga A, Terasaka N
Safety and Effectiveness of Four-Factor Prothrombin Complex
Concentrate in Special Populations with INR Below 2: A
Post-Marketing Surveillance Study
Cardiol Ther. 2024 SEP;13(3):603-614.
Journal Impact Factor 2021: N/A
大牟田病院
#呼吸器系
Wakamatsu K, Nagata N, Kumazoe H, Hara M, Asai S,
Noda N, Kiyotani R, Fukui I, Tatsuta M,
Katahira K, Akasaki T, Maki S, Miyamoto K,
Otsuka J, Izumi M, Kawasaki M, Yamada H
Prognostic performance of Krebs von den Lungen-6, surfactant
protein A, surfactant protein D levels in the serum and
bronchoalveolar lavage fluid in chronic fibrosing interstitial
pneumonia: a retrospective study
BMC Pulm Med. 2024 AUG 22;24(1)
Journal Impact Factor 2021: 3.32
#臨床神経学
Ono N, Suzuyama K, Minagawa H, Uwatoko K, Yoshikawa M, Ide T, Mitsuoka
M, Honda K, Hirai T, Otsuka T, Kai KT, Honda H, Kitamoto T,
Irie H, Yukitake M, Koike H
Involvement of the nigrostriatal system in
Gerstman-Straussler-Scheinker disease with the PRNP-P102L
mutation
J Neurol Sci. 2024 SEP 15;464
Journal Impact Factor 2021: 4.553
肥前精神医療センター
#臨床神経学 #レビュー論文
Kato T, Ogasawara K, Motomura K, Kato M, Tanaka T, Takaesu Y,
Nio S, Kishi T, So MR, Nemoto K, Suzuki E, Watanabe K, Matsuo K, JSMD
Bipolar Disorder Guidelines Revision Working Grp, JSMD Bipolar
Disorder Comm, JSMD Gidelines Comm
Practice Guidelines for Bipolar Disorder by the JSMD (Japanese
Society of Mood Disorders)
Psychiatry Clin Neurosci. 2024 NOV;78(11):633-645.
Journal Impact Factor 2021: 12.145
嬉野医療センター
#呼吸器系 #観察研究 #多施設共同研究
Taniguchi Y, Tamiya A, Osuga M, Harada D,
Isa SI, Nakamura K, Mizumori Y,
Shinohara T, Yanai H, Nakatomi K, Oki M,
Mori M, Kuwako T, Yamazaki K, Tamura A,
Ando M, Koh Y
Baseline genetic abnormalities and effectiveness of osimertinib
treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC
based on performance status
BMC Pulm Med. 2024 AUG 24;24(1)
Journal Impact Factor 2021: 3.32
#外科学
Shiraishi T, Nonaka T, Tominaga T, Takamura Y, Oishi K, Hashimoto S,
Noda K, Ono R, Hisanaga M, Takeshita H, Ishii M,
Oyama S, Ishimaru K, Kunizaki M, Sawai T, Matsumoto K
The C-reactive protein-albumin-lymphocyte (CALLY) index is a useful
predictor of postoperative complications in patients with a colonic
stent for obstructive colorectal cancer: a Japanese multicenter
study
Surg Today. 2024 AUG 23;
Journal Impact Factor 2021: 2.54
#腫瘍学 #多施設共同研究 #観察研究
Tamiya A, Osuga M, Harada D, Isa SI, Taniguchi Y,
Nakamura K, Mizumori Y, Shinohara T,
Yanai H, Nakatomi K, Oki M, Mori M,
Kuwako T, Yamazaki K, Tamura A, Ando M, Koh Y
Mechanisms of resistance and correlation between pre-treatment
co-alterations and p-prognosis to osimertinib in chemo-naïve
advanced non-small cell lung cancer
Lung Cancer. 2024 SEP;195
Journal Impact Factor 2021: 6.081
長崎医療センター
#外科学
Shiraishi T, Nonaka T, Tominaga T, Takamura Y, Oishi K, Hashimoto S,
Noda K, Ono R, Hisanaga M, Takeshita H, Ishii M,
Oyama S, Ishimaru K, Kunizaki M, Sawai T, Matsumoto K
The C-reactive protein-albumin-lymphocyte (CALLY) index is a useful
predictor of postoperative complications in patients with a colonic
stent for obstructive colorectal cancer: a Japanese multicenter
study
Surg Today. 2024 AUG 23;
Journal Impact Factor 2021: 2.54
#リウマチ学
Higuchi T, Oka S, Shimada K, Tsunoda S, Ito S,
Okamoto A, Fujimori M, Nakamura T, Katayama M,
Suzuki M, Saisho K, Shinohara S, Matsui T,
Migita K, Nagaoka S, Tohma S, Furukawa H
Association of rare single-nucleotide variant MUC5B rs35705950 with
interstitial lung disease in Japanese rheumatoid arthritis
RHEUMATOLOGY. 2024 AUG 19;
Journal Impact Factor 2021: 7.046
熊本医療センター
#血液学 #ランダム化比較試験 #第III相試験 #多施設共同研究
Shimoda K, Komatsu N, Matsumura I, Ikeda K, Hino M, Hidaka M,
Maeda Y, Kondo T, Fujisaki T, Shoshi K, Azuma K, Fukushima R,
Kawashima J, Kosugi H
Momelotinib versus ruxolitinib in JAK inhibitor-naïve patients with
myelofibrosis: an efficacy/safety analysis in the Japanese subgroup
of the phase 3 randomized SIMPLIFY-1 trial
Int J Hematol. 2024 SEP;120(3):314-324.
Journal Impact Factor 2021: 2.324
別府医療センター
#免疫学
Otsuki T, Akada S, Anami A, Kosaka K, Munjal I, Baber J, Shoji
Y, Aizawa M, Swanson KA, Gurtman A
Efficacy and safety of bivalent RSVpreF maternal vaccination to
prevent RSV illness in Japanese infants: Subset analysis from the
pivotal randomized phase 3 MATISSE trial
Vaccine. 2024 SEP 17;42(22)
Journal Impact Factor 2021: 4.169
都城医療センター
#リウマチ学
Higuchi T, Oka S, Shimada K, Tsunoda S, Ito S,
Okamoto A, Fujimori M, Nakamura T, Katayama M,
Suzuki M, Saisho K, Shinohara S, Matsui T,
Migita K, Nagaoka S, Tohma S, Furukawa H
Association of rare single-nucleotide variant MUC5B rs35705950 with
interstitial lung disease in Japanese rheumatoid arthritis
RHEUMATOLOGY. 2024 AUG 19;
Journal Impact Factor 2021: 7.046
#外科学
Ogawa K, Komori H, Tajiri T, Horino T, Kato R,
Ohuchi M, Miyamoto Y, Baba H
Association of Acute Care Surgeon Involvement With PostSurgery
Complications
J Surg Res. 2024 SEP;301:640-646.
Journal Impact Factor 2021: 2.417
宮崎病院
#腫瘍学
Minato A, Furubayashi N, Tomoda T, Masaoka H, Song Y,
Hori Y, Kiyoshima K, Negishi T, Kuroiwa K, Seki
N, Tomisaki I, Nakamura M, Harada K, Fujimoto N
Clinical Outcomes of Enfortumab Vedotin in Advanced Urothelial
Carcinoma With Prior Avelumab Versus Pembrolizumab Therapy
Anticancer Res. 2024 AUG;44(8):3419-3426.
Journal Impact Factor 2021: 2.435
#腫瘍学
Furubayashi N, Minato A, Tomoda T, Masaoka H, Hori Y,
Kiyoshima K, Negishi T, Haraguchi Y, Koga T, Song
YHY, Harada K, Kuroiwa K, Seki N, Fujimoto N,
Nakamura M, Uro-Oncology Grp Kyushu UROKYU
Enfortumab Vedotin for Elderly Advanced Urothelial Carcinoma
Patients or Those With a Poor Performance Status
Anticancer Res. 2024 AUG;44(8):3409-3417.
Journal Impact Factor 2021: 2.435
#老年医学 #老年学 #多施設共同研究
Nishimura A, Masuda C, Murauchi C, Ishii M, Murata Y, Kawasaki T,
Azuma M, Arai H, Harashima SI
Regional differences in frailty among older adults with type 2
diabetes: a multicenter cross-sectional study in Japan
BMC Geriatr. 2024 AUG 17;24(1)
Journal Impact Factor 2021: 4.07
鹿児島医療センター
#臨床神経学
Hamada Y, Matsuoka H, Sato S, Kawabata Y,
Iwamoto K, Ikeda M,
Sato T, Takaguchi G, Takashima H
Combining the deployment of only the distal basket segment of the
EMBOTRAP III and an aspiration catheter for M2 occlusions: the
ONE-SEG technique
Front Neurol. 2024 AUG 27;15
Journal Impact Factor 2021: 4.086
#皮膚病学 #症例報告
Hiraki T, Mori H, Misawa J, Yunoki M, Goto K
NRASQ61R-driven atypical melanocytic tumor with
blue nevus-like morphology: A case report
J Cutan Pathol. 2024 DEC;51(12):948-953.
Journal Impact Factor 2021: 1.458
#腫瘍学
Muto Y, Kambayashi Y, Kato H, Mizuhashi S, Ito T, Maekawa T, Ishizuki
S, Uchi H,
Matsushita S, Yamamoto Y, Yoshino K, Fujisawa Y, Amagai R, Ohuchi K, Hashimoto A,
Fukushima S, Asano Y, Fujimura T
Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma
including Acral and Mucosal Subtypes
Cancers. 2024 AUG;16(15)
Journal Impact Factor 2021: 6.575
登録日: 2025年1月15日